A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Eli Lilly & CO stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 829,382 shares of LLY stock, worth $660 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares
829,382
Previous 827,681 0.21%
Holding current value
$660 Million
Previous $749 Million 1.95%
% of portfolio
1.35%
Previous 1.43%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $1.31 Million - $1.63 Million
1,701 Added 0.21%
829,382 $735 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $1.01 Million - $1.27 Million
-1,399 Reduced 0.17%
827,681 $749 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $56.4 Million - $75.4 Million
-95,208 Reduced 10.3%
829,080 $645 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $17.8 Million - $21 Million
-33,842 Reduced 3.53%
924,288 $539 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $9.87 Million - $13.6 Million
22,710 Added 2.43%
958,130 $515 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $88.7 Million - $119 Million
-252,773 Reduced 21.27%
935,420 $439 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $64.2 Million - $75.4 Million
206,551 Added 21.04%
1,188,193 $408 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $26.6 Million - $31 Million
82,765 Added 9.21%
981,642 $359 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $64.6 Million - $73.6 Million
-217,791 Reduced 19.5%
898,877 $291 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $37.3 Million - $43.8 Million
133,910 Added 13.63%
1,116,668 $362 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $5.87 Million - $7.29 Million
-25,000 Reduced 2.48%
982,758 $281 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $38.1 Million - $47.3 Million
-169,408 Reduced 14.39%
1,007,758 $278 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $81 Million - $99.7 Million
365,640 Added 45.06%
1,177,166 $272 Million
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $12.4 Million - $16.1 Million
-68,812 Reduced 7.82%
811,526 $186 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $79.3 Million - $103 Million
482,487 Added 121.27%
880,338 $164 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $8.35 Million - $11 Million
64,000 Added 19.17%
397,851 $67.2 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $17.7 Million - $20.5 Million
121,200 Added 56.99%
333,851 $49.4 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $89.4 Million - $108 Million
-655,400 Reduced 75.5%
212,651 $34.9 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $77 Million - $95.3 Million
646,490 Added 291.79%
868,051 $120 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $21 Million - $26 Million
-196,700 Reduced 47.03%
221,561 $29.1 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $6.99 Million - $7.61 Million
65,500 Added 18.57%
418,261 $46.8 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $80.6 Million - $94.1 Million
-727,345 Reduced 67.34%
352,761 $39.1 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $12.6 Million - $14.8 Million
-113,019 Reduced 9.47%
1,080,106 $140 Million
Q4 2018

Feb 14, 2019

SELL
$105.9 - $118.64 $3.51 Million - $3.94 Million
-33,190 Reduced 2.71%
1,193,125 $138 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $38 Million - $47.5 Million
-443,075 Reduced 26.54%
1,226,315 $132 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $5.75 Million - $6.6 Million
75,990 Added 4.77%
1,669,390 $142 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $6.22 Million - $7.35 Million
-83,870 Reduced 5.0%
1,593,400 $123 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $23.8 Million - $25.6 Million
290,775 Added 20.97%
1,677,270 $142 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $107 Million - $119 Million
1,386,495
1,386,495 $119 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.